These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23697247)

  • 41. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections.
    Saeliw P; Preechawai P; Aui-aree N
    J Med Assoc Thai; 2010 Oct; 93(10):1200-4. PubMed ID: 20973324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin for the treatment of essential blepharospasm.
    Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC
    Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Life satisfaction of two-year post-stroke survivors: effects of socio-economic factors, motor impairment, Newcastle stroke-specific quality of life measure and World Health Organization quality of life: bref of informal caregivers in Luxembourg and a rural area in Portugal.
    Baumann M; Lurbe K; Leandro ME; Chau N
    Cerebrovasc Dis; 2012; 33(3):219-30. PubMed ID: 22261643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AAN Updates Guidelines on the Uses of Botulinum Neurotoxin.
    Wilkes J
    Am Fam Physician; 2017 Feb; 95(3):198-199. PubMed ID: 28145664
    [No Abstract]   [Full Text] [Related]  

  • 45. Gender differences in benign essential blepharospasm.
    Lee MS; Johnson M; Harrison AR
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):169-70. PubMed ID: 22460669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sternutatory reflex induced by periocular needle insertion in patients receiving chronic botulinum toxin injections.
    Kulkarni OC; Cox CA; Hedges TR; Tarsy D
    Parkinsonism Relat Disord; 2013 Aug; 19(8):770-1. PubMed ID: 23680422
    [No Abstract]   [Full Text] [Related]  

  • 47. Asymmetric blepharospasm with bilateral curtain sign.
    de Souza A; Bhonsle SK
    Eur J Neurol; 2012 Dec; 19(12):e141-2. PubMed ID: 23157244
    [No Abstract]   [Full Text] [Related]  

  • 48. Blepharospasm in a patient with pontine capillary telangiectasia.
    Gilbert AL; Dillon WP; Horton JC
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):e92-3. PubMed ID: 22082598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new botulinum toxin potentially bioequivalent to onabotulinumtoxinA: are there any differences at all?
    Yang GH; Jung HH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):165-70. PubMed ID: 23301820
    [No Abstract]   [Full Text] [Related]  

  • 50. Promotion of cosmetic botulinum toxin A frowned upon.
    Larkin M
    Lancet; 2002 Sep; 360(9337):929. PubMed ID: 12354481
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevalence, indications and demographic characteristics of Botulinum neurotoxin use in a tertiary oculoplastic centre.
    De Silva I; Lim C; Thomas M; Berry-Brincat A; Sampath R; Burns J
    Eye (Lond); 2022 Jul; 36(7):1409-1411. PubMed ID: 34183791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Language modulation of benign essential blepharospasm.
    Waxman J; Hersh D; Murta F; Ezra DG
    Mov Disord; 2016 May; 31(5):764-5. PubMed ID: 26990543
    [No Abstract]   [Full Text] [Related]  

  • 53. Protective Effect of Blepharospasm on the Anterior Segment of the Eye.
    Biuk D; Vinković M; Barać J; Biuk E; Zelić Z; Matić S
    Acta Clin Croat; 2018 Mar; 57(1):130-133. PubMed ID: 30256021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health-related quality of life in blepharospasm and hemifacial spasm.
    Tan EK; Seah A
    Arch Ophthalmol; 2007 Aug; 125(8):1141; author reply 1141. PubMed ID: 17698774
    [No Abstract]   [Full Text] [Related]  

  • 55. An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm.
    Kilic-Berkmen G; Kim H; Chen D; Yeo CI; Dinasarapu AR; Scorr LM; Yeo WH; Peterson DA; Williams H; Ruby A; Mills R; Jinnah HA
    Mov Disord; 2024 Apr; 39(4):738-745. PubMed ID: 38310362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation.
    Emoto Y; Emoto H; Oishi E; Hikita S; Wakakura M
    Drug Healthc Patient Saf; 2011; 3():9-14. PubMed ID: 21753898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of GABAergic System in Blepharospasm.
    Suzuki Y; Ishii K; Kiyosawa M
    J Neuroophthalmol; 2016 Sep; 36(3):349-50. PubMed ID: 27533531
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of GABAergic System in Blepharospasm: Response.
    Evinger C; Digre K
    J Neuroophthalmol; 2016 Sep; 36(3):350-2. PubMed ID: 27533532
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical categorization of psychogenic blepharospasm.
    Gazulla J; García-Rubio S; Ruiz-Gazulla C; Modrego P
    Parkinsonism Relat Disord; 2015 Mar; 21(3):325-6. PubMed ID: 25558013
    [No Abstract]   [Full Text] [Related]  

  • 60. Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
    Hanganu A; Muthuraman M; Chirumamilla VC; Koirala N; Paktas B; Deuschl G; Zeuner KE; Groppa S
    PLoS One; 2017; 12(2):e0172374. PubMed ID: 28192485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.